OA08.06 Sacituzumab Govitecan vs Docetaxel in Patients with mNSCLC Non-responsive to Last Anti-PD-(L)1-containing Regimen: EVOKE-01

Autor: Garassino, M.C., Juan-Vidal, O., Felip, E., Girard, N., Cobo Dols, M., Haggstrom, D.E., Reinmuth, N., Tiseo, M., Hochmair, M.J., Summers, Y., Hendriks, L.E.L., Daniel, D.B., Kato, T., Cheema, P., Mekan, S., Patel, R., Zhang, E., Paz-Ares, L.G.
Zdroj: Journal of Thoracic Oncology; October 2024, Vol. 19 Issue: 10, Number 10 Supplement 1 pS26-S27, 2p
Databáze: Supplemental Index